Hyliion
HYLN
3.82
-0.04
-0.91%
Hyliion
US · HYLN
#3527 by market cap
3.82
-0.04
-0.91%
Live - 5344 symbols - heartbeat 28s ago
· 2026-10-08 10:09
Pre-market
3.91
+1.43%
After-hours
3.89
+1.04%
Overnight
3.85
0.00%
- Market cap
- 681.35M
- P/E (TTM)i
- -13.16
- P/Bi
- 4.02
- EPSi
- -0.33
- Div yieldi
- 0.00%
- 52W posi
- 33%
Reader sentiment
Are you bullish or bearish on HYLN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 33.46, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year +130.29% YoY
Margins
- Gross margin
- 4.89%
- Operating margin
- -1,872.06%
- Net margin
- -1,645.70%
Key ratios & quality
- Altman Z-Scorei
- 33.46
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 200.00K | 2.11M | 672.00K | 1.51M | 3.48M |
| Gross profit | 0 | 0 | -2.54M | -6.67M | -1.04M | 94.00K | 170.00K |
| Selling & admin expenses | 2.73M | 9.59M | 35.30M | 41.99M | 42.61M | 24.38M | 22.76M |
| Research & development | 9.27M | 12.60M | 58.26M | 110.37M | 82.24M | 37.00M | 42.47M |
| Operating profit | -12.00M | -22.18M | -96.10M | -159.03M | -125.90M | -61.29M | -65.05M |
| Pretax profit | -14.11M | 324.12M | -96.05M | -153.36M | -123.51M | -52.05M | -57.19M |
| Tax | -- | -- | -- | -- | -- | -- | -- |
| Net profit | -14.11M | 324.12M | -96.05M | -153.36M | -123.51M | -52.05M | -57.19M |
| Basic EPS | 0 | 3 | -1 | -1 | -1 | 0 | 0 |
| Diluted EPS | -0.09 | -0.35 | -0.56 | -0.87 | -0.68 | -0.30 | -0.33 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 489.00K | 1.52M | 759.00K | 712.00K | 2.83M | 4.94M |
| Gross profit | 12.00K | 131.00K | -47.00K | 74.00K | 210.00K | 366.00K |
| Selling & admin expenses | 6.08M | 5.96M | 5.18M | 5.53M | 6.18M | 6.43M |
| Research & development | 12.23M | 10.14M | 10.14M | 9.96M | 7.67M | 9.50M |
| Operating profit | -18.30M | -15.97M | -15.37M | -15.42M | -13.64M | -15.56M |
| Pretax profit | -17.25M | -13.41M | -13.34M | -13.18M | -11.74M | -13.93M |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -17.25M | -13.41M | -13.34M | -13.18M | -11.74M | -13.93M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.10 | -0.08 | -0.08 | -0.07 | -0.07 | -0.08 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 6.84M | 612.37M | 386.48M | 324.21M | 181.70M | 131.03M | 98.63M |
| Cash & ST investments | 6.29M | 591.59M | 377.23M | 313.21M | 163.18M | 120.15M | 92.37M |
| Inventory | -- | 132.00K | 114.00K | 74.00K | -- | -- | -- |
| Total assets | 14.10M | 655.09M | 578.44M | 446.74M | 328.38M | 263.05M | 203.56M |
| Total current liabilities | 12.36M | 8.76M | 15.24M | 14.68M | 15.12M | 14.29M | 9.86M |
| Short-term debt | 7.67M | 734.00K | 21.00K | 347.00K | 847.00K | 2.43M | 2.73M |
| Long-term debt | 9.68M | 908.00K | -- | -- | -- | -- | -- |
| Total liabilities | 32,165,000.00 | 14,921,000.00 | 24,525,000.00 | 23,169,000.00 | 22,117,000.00 | 18,657,000.00 | 11,550,000.00 |
| Total equity | -18.07M | 640.17M | 553.92M | 423.57M | 306.27M | 244.39M | 192.01M |
| Retained earnings | -48.97M | 275.15M | 179.10M | 25.75M | -97.76M | -149.81M | -207.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 127.97M | 114.53M | 109.96M | 98.63M | 81.45M | 71.63M |
| Cash & ST investments | 121.11M | 108.56M | 105.00M | 92.37M | 72.47M | 64.18M |
| Inventory | -- | -- | -- | -- | 1.92M | 1.16M |
| Total assets | 240.98M | 229.21M | 216.23M | 203.56M | 190.75M | 179.59M |
| Total current liabilities | 9.24M | 10.26M | 9.98M | 9.86M | 8.07M | 9.43M |
| Short-term debt | 2.50M | 2.57M | 2.64M | 2.73M | 2.80M | 2.47M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 12,989,000.00 | 13,340,000.00 | 12,377,000.00 | 11,550,000.00 | 9,027,000.00 | 10,050,000.00 |
| Total equity | 227.99M | 215.87M | 203.86M | 192.01M | 181.72M | 169.54M |
| Retained earnings | -167.07M | -180.48M | -193.82M | -207.00M | -218.74M | -232.67M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -11.07M | -22.94M | -80.50M | -116.88M | -116.96M | -56.74M | -46.55M |
| Depreciation & amortization | 1.03M | 850.00K | 884.00K | 1.23M | 3.51M | 3.15M | 5.96M |
| Free cash flow | -11.42M | -23.26M | -82.88M | -134.19M | -124.36M | -73.26M | -70.29M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | -33.00K | -13.98M | 0 |
| Ending cash balance | 6.29M | 389.71M | 259.11M | 120.13M | 21.46M | 9.89M | 23.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -14.00M | -10.00M | -10.69M | -11.86M | -12.73M | -7.09M |
| Depreciation & amortization | 1.14M | 1.29M | 1.64M | 1.89M | 2.11M | 2.12M |
| Free cash flow | -21.34M | -14.24M | -21.12M | -13.60M | -14.60M | -7.30M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 13.00M | 16.26M | 18.54M | 23.60M | 20.93M | 13.83M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -12.60 | -16.09 | -31.38 | -33.85 | -18.90 | -26.21 |
| ROA %i | -100.12 | -11.79 | -15.63 | -29.92 | -31.87 | -17.60 | -24.51 |
| ROIC %i | -- | -10.36 | -16.01 | -32.03 | -36.87 | -22.74 | -29.29 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | 0.80 | -25.28 |
| EBIT margin %i | -- | -- | -48,024.00 | -7,281.91 | -18,734.38 | -4,061.76 | -1,872.06 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.55 | 69.89 | 25.37 | 22.08 | 12.02 | 9.17 | 10.00 |
| Quick ratioi | 0.52 | 67.53 | 24.77 | 21.41 | 10.79 | 8.54 | 9.41 |
| Debt / assetsi | 157.19 | 1.03 | 1.49 | 1.64 | 2.33 | 2.58 | 2.15 |
| LT debt / equityi | -- | 0.93 | 1.56 | 1.65 | 2.22 | 1.79 | 0.86 |
| Interest coveragei | -3.33 | -6.18 | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | 96.13 | 18.17 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -21.13 | -23.27 | -25.31 | -26.21 | -25.22 | -27.08 |
| ROA %i | -19.94 | -22.04 | -23.91 | -24.51 | -23.94 | -25.53 |
| ROIC %i | -24.89 | -26.87 | -28.64 | -29.29 | -28.14 | -29.80 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -3,254.80 | -1,890.89 | -1,560.96 | -1,872.06 | -1,038.09 | -648.68 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 13.85 | 11.16 | 11.02 | 10.00 | 10.09 | 7.59 |
| Quick ratioi | 13.33 | 10.70 | 10.59 | 9.41 | 9.35 | 7.09 |
| Debt / assetsi | 2.58 | 2.45 | 2.31 | 2.15 | 1.95 | 1.70 |
| LT debt / equityi | 1.63 | 1.41 | 1.15 | 0.86 | 0.50 | 0.34 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Research and development services100.00%
Quote time 2026-10-08 10:09:15 · For reference only, not investment advice and not tailored to your situation.